Home › Funds › Vestal Point Capital, LP › ZYME
Vestal Point Capital, LP position in ZYME
ZYMEWORKS INC · Health Care
Vestal Point Capital, LP reported holding 600,000 shares of ZYME (ZYMEWORKS INC) in its Q3 2026 13F filing — a position valued at US$15.9M, representing 0.41% of its reported portfolio and ranking #32 among its reported holdings. Vestal Point Capital, LP has disclosed ZYME holdings in 8 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's ZYME position evolved
Vestal Point Capital, LP first disclosed a stake in ZYME in Q2 2024 at 440,000 shares (US$3.7M). The position peaked in Q3 2025 at 1,765,000 shares, worth US$30.1M. Across 8 filings, Vestal Point Capital, LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 600,000 shares valued at US$15.9M. Notable position changes include a 70% trim in Q4 2024 (shares fell 19% over the following quarter), a 170% increase in Q1 2025 (shares rose 5% over the following quarter), a 130% increase in Q2 2025 (shares rose 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 440.00K | $3.74M | New |
| Q3 2024 | 615.00K | $7.72M | Add |
| Q4 2024 | 185.00K | $2.71M | Reduce |
| Q1 2025 | 500.00K | $5.96M | Add |
| Q2 2025 | 1.15M | $14.43M | Add |
| Q3 2025 | 1.76M | $30.15M | Add |
| Q4 2025 | 865.00K | $22.78M | Reduce |
| Q3 2026 | 600.00K | $15.89M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZYME and 13F data
ZYME (ZYMEWORKS INC) is a Health Care company. 27 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$608.5M), Rubric Capital Management LP (US$185.4M), PERCEPTIVE ADVISORS LLC (US$93.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZYME
- EcoR1 Capital, LLC 22.97M sh · $608.49M · Q3 2026
- Rubric Capital Management LP 7.00M sh · $185.43M · Q3 2026
- PERCEPTIVE ADVISORS LLC 3.55M sh · $93.92M · Q3 2026
- BVF INC/IL 3.46M sh · $91.77M · Q3 2026
- Nextech Invest Ltd. 1.11M sh · $29.51M · Q3 2026
- Prosight Management, LP 721.10K sh · $19.10M · Q3 2026
- Redmile Group, LLC 491.65K sh · $13.02M · Q3 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held ZYME?
Vestal Point Capital, LP has disclosed ZYME holdings in 8 of the last 10 reported quarters, going back to Q2 2024.
What is Vestal Point Capital, LP's current position in ZYME?
As of Q3 2026, Vestal Point Capital, LP holds 600.00K shares of ZYME (ZYMEWORKS INC), valued at $15.89M, representing 0.41% of its reported portfolio and ranking #32.
Has Vestal Point Capital, LP been buying or selling ZYME?
In the latest 13F filing (Q3 2026), Vestal Point Capital, LP newly opened its position in ZYME. The position peaked in Q3 2025 at 1.76M shares.
Which other funds hold ZYME?
Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.